Intent to Sole Source - 10x Genomics Chromium Single Cell 5' v2 Reagent Kit
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health (NIH) has issued an Intent to Sole Source for the procurement of the 10X Genomics Chromium Single Cell 5' v2 Reagent Kit. This acquisition, valued at an estimated $24,150.17, is intended for 10X Genomics, Inc. to support the Early Detection of Lung Diseases (EDLI) project in Bethesda, MD. This is a notice of intent, not a request for proposal.
Purpose & Scope
NIH requires the proprietary 10X Genomics 5' v2 Kit to enable cutting-edge single-cell and multiomic analyses. These reagents are exclusively designed for the 10X Genomics Chromium platform and are critical for high-resolution gene expression profiling, immune repertoire analysis, and other advanced applications. The kit is essential for identifying early biomarkers and understanding molecular mechanisms of infectious and noninfectious lung diseases, directly supporting the EDLI project's objectives. The acquisition includes proprietary reagents, consumables, and supporting components necessary for data integrity, reproducibility, and experimental consistency.
Contract Details
- Opportunity Type: Special Notice (Intent to Sole Source)
- Estimated Value: $24,150.17
- Proposed Contractor: 10X Genomics, Inc.
- Statutory Authority: FAR 13.106-1(b)(1) (Purchases not exceeding the simplified acquisition threshold where only one source is reasonably available) and 41 U.S.C. 253(c)(1) as implemented by FAR 6.302-1.
- Justification: The 10X Genomics 5' v2 Kit is a proprietary product with unique, patented technology. No alternative supplies can meet the technical specifications and compatibility requirements of the Chromium system without compromising experimental continuity, data accuracy, and reproducibility. 10X Genomics, Inc. is the sole manufacturer and supplier.
- Agency: Department of Health and Human Services, National Institutes of Health (NIH), Clinical Center.
- Place of Performance: Bethesda, MD.
Response Information
- Response Type: Capability Statement
- Submission Deadline: May 21, 2026, by 12:00 PM Eastern Standard Time.
- Submission Method: Email to valerie.gregorio@nih.gov.
- Email Subject Line: Must reference "NOI-CC-OLAO-26-005835".
Additional Notes
This is not a Request for Proposal. All responsible sources capable of providing the required items may submit a capability statement for consideration. A determination not to compete this requirement, based on responses, is solely at the Government's discretion. NIH currently receives a 25% discount on 10X Genomics products.